Alger Health Sciences Fund Class A (AHSAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

29.85

-0.20 (-0.67%)

At close: Aug 26, 2026

57.35% (1Y)

Fund Assets	75.36M
Expense Ratio	1.17%
Min. Investment	$1,000
Turnover	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	n/a

Previous Close	30.05
YTD Return	30.92%
1-Year Return	57.35%
5-Year Return	1.02%
52-Week Low	19.14
52-Week High	30.08
Beta (5Y)	0.59
Holdings	56
Inception Date	May 1, 2002

About AHSAX

AHSAX was founded on 2002-05-01. The Fund's investment strategy focuses on Health/Biotech with 1.04% total expense ratio. The minimum amount to invest in Alger Funds: Alger Health Sciences Fund; Class A Shares is $1,000 on a standard taxable account. Alger Funds: Alger Health Sciences Fund; Class A Shares seeks long-term capital appreciation. AHSAX invests at least 80% of its net assets in equity securities of companies of any market cap that are engaged in the health sciences sector, including health care services, pharmaceuticals, medical equipment and supplies, and applied research and development.

Category Health

Performance Rating Average

Risk Rating Average

Stock Exchange NASDAQ

Ticker Symbol AHSAX

Share Class Class A

Index S&P 500 TR

Performance

AHSAX had a total return of 57.35% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.67%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIKCX	Fidelity	Fidelity Advisor Health Care Z	0.56%
FSPHX	Fidelity	Fidelity Select Health Care Portfolio	0.62%
FIJYX	Fidelity	Fidelity Advisor Biotechnology Z	0.58%
FSHCX	Fidelity	Fidelity Select Health Care Services Portfolio	0.67%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.96%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
AHSZX	Class Z	0.76%
AHSCX	Class C	1.96%

Top 10 Holdings

37.50% of assets

Name	Symbol	Weight
Impulse Dynamics Ireland Series F-3	n/a	4.90%
Bruker Corporation	BRKR	4.56%
Teva Pharmaceutical Industries Limited	TEVA	4.55%
Merck & Co., Inc.	MRK	4.40%
CVS Health Corporation	CVS	3.46%
Eli Lilly and Company	LLY	3.44%
Novo Nordisk A/S	NVO	3.20%
Forte Biosciences, Inc.	FBRX	3.02%
Welltower Inc.	WELL	3.01%
Guardant Health, Inc.	GH	2.96%

View More Holdings